BIPOLAR DISORDERS
©Dr.Ankit Srivastava
BIBILOGRAPHY:
The British Journal of Psychiatry 2001;(Suppl
41):142–147.
Blackwood DH, Visscher PM, Muir WJ. Genetic studies
ofbipolar affective disorder in large families. The British
Journal of Psychiatry 2001; (Suppl 41):134–136.
Bowden CL, Brugger AM, Swann AC, et al. Efficacy of
divalproex vs lithium and placebo in the treatment of
mania. The Depakote Mania Study Group. The Journal of
the American Medical Association 1994;271: 918–924.
Bowden CL, Calabrese JR, McElroy SL, et al. A
randomized, placebocontrolled 12-month trial of
divalproex and lithium in treatment of outpatients with
Bipolar I disorder. Divalproex Maintenance Study Group.
Archives of General Psychiatry 2000;57:481–489.
Bunney WE, Murphy D, Goodwin FK, et al. The “switch
process” in manic depressive illness. I. A systematic study
of sequential behavior change. Archives of General
Psychiatry 1972;27:295–302.
Calabrese JR, Bowden CL, Sachs GS, et al. A double-
blind placebo-controlled study of lamotrigine in
outpatients with bipolar I depression. Lamictal 602 Study
Group. The Journal of Clinical Psychiatry 1999;60:79–88.
Carlson GA, Goodwin FK. The stages of mania: a
longitudinal analysis of the manic episode. Archives of
General Psychiatry 1973;28:221–228.
Chaudron LH, Jefferson JW. Mood stabilizers during
breastfeeding: a review. The Journal of Clinical
Psychiatry 2000;61:79–90.
Craddock N, Jones I. Molecular genetics of bipolar
disorder. The British Journal of Psychiatry 2001;(Suppl
41):128–133.
Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of
standard and low serum levels of lithium for maintenance
treatment of bipolar disorder. The New England Journal of
Medicine 1989;321:1489–1493.
Goodwin FK. Rationale for long-term treatment of bipolar
disorder and evidence for long-term lithium treatment. The
Journal of Clinical Psychiatry 2002;63(Suppl 10):5–12.
Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium
versus carbamazepine in the maintenance treatment of
bipolar disorders—a randomized study. Journal of
Affective Disorders 1997;43:151–161.
Himmelhoch JM, Mulla D, Neil JF, et al. Incidence and
significance of mixed affective states in a bipolar
population. Archives of General Psychiatry
1976;33:1062–1066.
Janowsky DS, El-Yousef K, David JM, et al.
Parasympathetic suppression of manic symptoms by
physostigmine. Archives of General Psychiatry
1973;28:542– 547.
Joffe RT, MacQueen GM, Marriott M, et al. Induction of
mania and cycle acceleration in bipolar disorder: effect of
different classes of antidepressant. Acta Psychiatrica
Scandinavica 2002;105:427–430.
Keck PE, Versiani M, Potkin S, et al. Ziprasidone in the
treatment of acute mania: a three-week, placebo-
controlled, double-blind, randomized trial. The American
Journal of Psychiatry 2003;160:741–748.
Kramlinger KG, Post RM. Adding lithium carbonate to
carbamazepine: antimanic efficacy in treatment-resistant
mania. Acta Psychiatrica Scandinavica 1989;79:378–385.
Lam DH, Watkins ER, Hayward P, et al. A randomized
controlled study of cognitive therapy for relapse
prevention for bipolar affective disorder: outcome of the
first year. Archives of General Psychiatry 2003;60:145–
152.
Lipkin KM, Dyrud J, Meyer GG. The many faces of
mania: therapeutic trial of lithium carbonate. Archives of
General Psychiatry 1970;22:262–267.
Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs
lithium in the treatment and prophylaxis of mania. The
British Journal of Psychiatry 1988;153:198–204.
McElroy SL, Keck PE, Stanton SP, et al. A randomized
comparison of divalproex oral loading versus haloperidol
in the initial treatment of acute psychotic mania. The
Journal of Clinical Psychiatry 1996;57:142–146.
McIntyre RS, Mancini DA, McCann S, et al. Topiramate
versus bupropion SR when added to mood stabilizer
therapy for the depressive phase of bipolar disorder: a
preliminary single-blind study. Bipolar Disorders
2002;4:207–213.
Meehan K, Zhang F, David S, et al. A double-blind,
randomized comparison of the efficacy and safety of
intramuscular injections of olanzapine, lorazepam, or
placebo in treating acutely agitated patients diagnosed
with bipolar mania. Journal of Clinical
Psychopharmacology 2001; 21:389–397.
Mukherjee S, Sackheim HA, Schnur DB.
Electroconvulsive therapy of acute manic episodes: a
review of 50 years’ experience. The American Journal of
Psychiatry 1994;151:169–176.
Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar
disorder. Lancet 2002;359:241–247.